1. PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events: a clinical practice guideline with risk-stratified recommendations. (4th May 2022) Authors: Hao, Qiukui; Aertgeerts, Bert; Guyatt, Gordon; Bekkering, Geertruida E; Vandvik, Per Olav; Khan, Safi U; Rodondi, Nicolas; Jackson, Rod; Reny, Jean-Luc; Al Ansary, Lubna; Van Driel, Mieke; Assendelft, Willem J J; Agoritsas, Thomas; Spencer, Frederick; Siemieniuk, Reed A C; Lytvyn, Lyubov; Heen, A... Journal: BMJ Issue: Volume 377(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗